The authors of this study conclude that pregnant women with pre-gestational diabetes on metformin are at an increased risk for multiple adverse pregnancy outcomes. However, they note that risk appears to be due to the underlying diabetes, with no indication of a teratogenic or abortifacient effect of metformin itself.